| Title : alpha\/beta-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases - Bononi_2021_J.Med.Chem_64_9759 |
| Author(s) : Bononi G , Tuccinardi T , Rizzolio F , Granchi C |
| Ref : Journal of Medicinal Chemistry , : , 2021 |
| Abstract : Much of the experimental evidence in the literature has linked altered lipid metabolism to severe diseases such as cancer, obesity, cardiovascular pathologies, diabetes, and neurodegenerative diseases. Therefore, targeting key effectors of the dysregulated lipid metabolism may represent an effective strategy to counteract these pathological conditions. In this context, alpha/beta-hydrolase domain (ABHD) enzymes represent an important and diversified family of proteins, which are involved in the complex environment of lipid signaling, metabolism, and regulation. Moreover, some members of the ABHD family play an important role in the endocannabinoid system, being designated to terminate the signaling of the key endocannabinoid regulator 2-arachidonoylglycerol. This Perspective summarizes the research progress in the development of ABHD inhibitors and modulators: design strategies, structure-activity relationships, action mechanisms, and biological studies of the main ABHD ligands will be highlighted. |
| ESTHER : Bononi_2021_J.Med.Chem_64_9759 |
| PubMedSearch : Bononi_2021_J.Med.Chem_64_9759 |
| PubMedID: 34213320 |
| Gene_locus related to this paper: human-ABHD3 |
| Gene_locus related to this paper: human-ABHD3 |
Bononi G, Tuccinardi T, Rizzolio F, Granchi C (2021)
alpha\/beta-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases
Journal of Medicinal Chemistry
:
Bononi G, Tuccinardi T, Rizzolio F, Granchi C (2021)
Journal of Medicinal Chemistry
: